HMGCR and hematopoietic and lymphoid cell neoplasm: HMGCR overexpression enhances cancer progression and metastasis, while its inhibition can suppress tumors; therefore, HMGCR has been used to treat solid cancers, hematological cancers, and tumors with drug resistance (16–18).